Circulation Cardiovascular Quality and Outcomes · 2020 · 13 citations · 4 references
MedicineInfectious DiseasesSurgeryCardiothoracic SurgeryClinical CardiologyVascular SurgeryAcute Coronary Syndrome InterventionAcute Coronary SyndromesCardiovascular DiseaseCoronary Artery DiseaseCoronary Artery SurgeryIschemic Heart DiseaseAcute Coronary Syndrome ManagementAtherosclerotic Plaque RuptureMicrocirculatory AlterationsSars-cov-2 InfectionSevere Acute Respiratory Syndrome
oronavirus disease 2019 (COVID-19) caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the pandemic, causing unprecedented health and social crisis worldwide.Patients with acute coronary syndromes, especially when coronary artery bypass graft (CABG) surgery is needed, may present with higher severity risk if affected by COVID-19.Extracorporeal circulation leads to activation of endothelium and microcirculatory network, which activates the coagulation, platelet aggregation, and inflammation. 1COVID-19 may also course with severe inflammation, massive secretion of inflammatory cytokines, plaque rupture, and a procoagulant state. 2 Therefore, it is advisable to postpone surgeries interventions when possible.However, our institution is a public tertiary referral hospital for high-risk cardiovascular patients even in SARS-CoV-2 pandemic.We describe a series of 13 patients with high-risk coronary artery disease submitted to CABG and who had COVID-19 infection during the same hospitalization, 6 patients had COVID-19 before surgery, 3 patients were operated with active infection, and 4 patients were infected after surgery.All patients were admitted with severe multivessel coronary disease, with clinical features requiring emergency procedures.By the definition of cardiac surgery recommendations during COVID-19 by Patel et al, 3 all patients were on high acuity cases and were not able to be discharged.Heart team decisions were made for all patients and infectious disease evaluation for COVID-19.We routinely tested for reverse-transcriptase polymerase chain reaction for SARS-CoV-2 24 to 48 hours before surgery.Positive or nonavailable COVID-19 tests had all personal protective equipment isolation measures in the operating room and isolated postoperative intensive care unit.During surgery, no extracorporeal circulation changes, were done in patients with COVID-19, and ultrafiltration was routinely used.Patients characteristics are summarized in Table. 4,5atients with positive reverse-transcriptase polymerase chain reaction for SARS-CoV-2 before surgery, waited at least 14 days or clinical symptoms resolution.After surgery, one died from septic shock and another patient died from severe encephalopathy.This encephalopathy had T2/fluid-attenuated inversion recovery hyperintense signal in hypothalamus and a diffuse microangiopathic pattern seen at brain magnetic resonance imaging.Two other patients had atrial fibrillation and 2 had no complications after surgery.Three patients were submitted to CABG at an emergent basis during active COVID-19 infection, because of clinical instability and before the PCR SARS-CoV-2 result was available.One died and the 2 others were discharged.This patient died in the third postoperative day of cardiogenic shock.The other patient, with a high surgical risk, did not develop important clinical manifestations of COVID-19 and was discharged 26 days after surgery.The third patient recovered from septic shock
4
Scott Simpson, Fernando Uliana Kay, Suhny Abbara et al. · Journal of Thoracic Imaging · 2020 · 798 citations · Full text